Ovarian cancer

Last updated: 01 November 2019

You can legally access new medicines, even if they are not approved in your country.

Learn more »

Rubraca (rucaparib), already approved as a treatment for BRCA positive ovarian cancer, has been approved as a maintenance therapy for ovarian cancer regardless of BRCA mutation. 

Read more